How PVOD is Caused and Diagnosed

Finding the cause of Pulmonary Venoocclusive Disease (PVOD) and reaching a definitive diagnosis is often a complex process. Because PVOD is so rare, it is frequently misdiagnosed as typical Pulmonary Arterial Hypertension (PAH) at first. However, understanding the specific triggers and the unique “fingerprints” this disease leaves on diagnostic tests is vital for ensuring you receive the correct care.

The Genetic Link: EIF2AK4

For some patients, PVOD is a heritable condition associated with pathogenic variants in a specific gene called EIF2AK4 ^[1]. This gene provides instructions for a protein (GCN2) that helps cells respond to stress. When this gene is mutated, it can lead to the abnormal growth and narrowing of the small veins in the lungs ^[2].

• Autosomal Recessive Inheritance: Biallelic pathogenic EIF2AK4 variants support an autosomal-recessive form of PVOD, meaning a patient inherits two copies of the mutated gene—one from each parent ^[3][4].
• Genetic Counseling: If you are found to have this mutation, genetic counseling is highly recommended to understand the implications for relatives. While your parents and children may be “carriers” with only one copy of the mutation, they typically do not develop the disease themselves ^[5][4].
• Sporadic Cases: It is important to note that many people with PVOD do not have this mutation, and testing can miss variants. A negative genetic result does not establish a specific cause or rule out PVOD; it simply means your case may be sporadic or associated with other factors ^[6].

Environmental and Acquired Associations

In cases where genetics do not play a role, researchers have identified several external triggers that have reported associations with PVOD.

• Chemotherapy: Certain cancer treatments, most notably the drug mitomycin C, have a strong reported association with the development of PVOD ^[7][8]. Other agents used in bone marrow or stem cell transplants have also been associated with changes in the lung’s blood vessels ^[9]. Review all chemotherapy and radiation history with your specialist.
• Industrial Solvents: Occupational exposure to organic solvents, particularly a degreaser called trichloroethylene (TCE), has been reported as an association in some limited studies ^[10].
• Other Associations: While less common, PVOD-like pathology has also been observed in some patients with connective tissue diseases like systemic sclerosis (scleroderma), though these diseases are associated with several forms of pulmonary hypertension ^[11].

The Challenge of Diagnosis

A diagnosis of PVOD usually begins with a procedure called Right Heart Catheterization (RHC). While this test is the gold standard for confirming high blood pressure in the lungs, it cannot tell the difference between PAH and PVOD on its own ^[12]. In both conditions, the pressure in the pulmonary artery is high, but the pressure in the left side of the heart (the “wedge pressure”) appears normal ^[13].

Because the “plumbing” looks similar on a heart cath, doctors must look for a combination of suggestive clues using other diagnostic tools. No single threshold confirms PVOD:

1. High-Resolution CT (HRCT) Scan: Doctors look for three specific signs: septal thickening (fluid-filled lines in the lung tissue), ground-glass opacities (hazy, cloud-like spots), and mediastinal lymphadenopathy (enlarged lymph nodes in the chest) ^[14][15]. These findings raise suspicion but can also reflect other conditions like interstitial lung disease or infection.
2. DLCO (Diffusion Capacity): In lung function tests, the DLCO measures how well oxygen moves from the air into your blood. In PVOD, this number is often markedly or disproportionately reduced compared to PAH because the veins and capillaries are too damaged to transfer oxygen efficiently ^[16][17]. DLCO is also affected by hemoglobin levels, smoking, and test quality.
3. Blood Oxygen Levels: Patients with PVOD typically have much lower oxygen levels (hypoxemia) than those with standard PAH, particularly when they try to walk or exercise ^[18][16].

Why Biopsy is Avoided

In many lung diseases, a doctor might take a small piece of tissue (biopsy) to get a definitive answer. In the case of PVOD, however, a surgical lung biopsy is considered extremely dangerous and is generally contraindicated ^[19]. Because the pressure in the lung’s blood vessels is so high and the veins are so fragile, a biopsy carries a life-threatening risk of uncontrollable bleeding ^[12][19].

Instead, modern medical guidelines recommend making a specialist clinical assessment integrating hemodynamics, imaging, pulmonary-function testing, genetics when appropriate, and the exclusion of alternatives ^[1]. If you have the EIF2AK4 mutation and the characteristic CT findings, this strongly supports the diagnosis without the need for risky surgery ^[20].